London: GSK has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...

GSK expects the European Commission to decide on approvals for both depemokimab and Nucala in the first quarter of 2026. GSK shares were 0.1% higher at 1,822.50 pence each on Friday afternoon in ...

An expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed seven new medicines for approval this ...

GlaxoSmithKline ( ($GB:GSK) ) has issued an update. GSK has announced that the European Medicines Agency’s Committee for Medicinal Products for ...

GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...

GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

By the way, GSK, realizing its potential in the MSI-H/dMMR market, is actively developing it for the treatment of colon ...

GSK wins FDA approval for Blujepa, a new oral antibiotic treatment option for uncomplicated urogenital gonorrhea.

Pittsburgh Steelers defensive tackle Cameron Heyward was diagnosed with asthma as a child and has had to manage it throughout his Ohio State and NFL football career.

The European Medicines Agency has recommended the approval of GSK's add-on drug to treat asthma and a chronic inflammatory ...

GSK secures FDA approval for its oral gonorrhoea drug as EMA backs expanded RSV vaccine and additional respiratory treatments ...